Poly Medicure vs Q-Line Biotech Ltd
Side-by-side stock comparison based on AI earnings call analysis
Which stock has stronger management signals?
Q-Line Biotech Ltd currently has the stronger revenue growth signal.
Poly Medicure and Q-Line Biotech Ltd show active capex signals based on earnings call analysis.
No strong fundraising signal is currently visible for either company.
| Metric | Poly Medicure | Q-Line Biotech Ltd |
|---|---|---|
| Current Price | ₹1,640 | ₹664 |
| Market Cap | ₹16,604.02 Cr. | ₹1,542.23 Cr. |
| Industry | — | — |
| P/E Ratio | 51.88 | 27.23 |
| ROE (%) | 9.02 | 25.97 |
| Debt/Equity | 0.11 | 0.92 |
| Sales Growth 5Y (%) | 19.01 | — |
| Profit Growth 5Y (%) | 17.85 | — |
| Promoter Holding (%) | 62.42 | 67.51 |
| Revenue Rank | Rank 3 | Rank 2 |
| Margin Rank | Rank 3 | Rank 1 |
| Signal | — | — |
| Capex | Yes | Yes |
| Fundraise | No information | No information |